Catia Marzolini

InstitutionUniversity of Liverpool
AddressLiverpool
United Kingdom
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 9 Covid-19 publications, with a maximum of 2 publications in August 2020 and December 2020
    All Publications
    Bar chart showing 52 publications over 19 distinct years, with a maximum of 8 publications in 2020
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Istampoulouoglou I, Zimmermanns B, Grandinetti T, Marzolini C, Harings-Kaim A, Koechlin-Lemke S, Scholz I, Bassetti S, Leuppi-Taegtmeyer AB. Cardiovascular adverse effects of lopinavir/ritonavir and hydroxychloroquine in COVID-19 patients: Cases from a single pharmacovigilance centre. Glob Cardiol Sci Pract. 2021 Jun 30; 2021(2):e202111. PMID: 34285902.
      Citations:    
    2. Mari A, Roloff T, Stange M, Søgaard KK, Asllanaj E, Tauriello G, Alexander LT, Schweitzer M, Leuzinger K, Gensch A, Martinez AE, Bielicki J, Pargger H, Siegemund M, Nickel CH, Bingisser R, Osthoff M, Bassetti S, Sendi P, Battegay M, Marzolini C, Seth-Smith HMB, Schwede T, Hirsch HH, Egli A. Global Genomic Analysis of SARS-CoV-2 RNA Dependent RNA Polymerase Evolution and Antiviral Drug Resistance. Microorganisms. 2021 May 19; 9(5). PMID: 34069681.
      Citations: 1     
    3. Marra F, Smolders EJ, El-Sherif O, Boyle A, Davidson K, Sommerville AJ, Marzolini C, Siccardi M, Burger D, Gibbons S, Khoo S, Back D. Recommendations for Dosing of Repurposed COVID-19 Medications in Patients with Renal and Hepatic Impairment. Drugs R D. 2021 Mar; 21(1):9-27. PMID: 33336316.
      Citations: 3     Fields:    Translation:Humans
    4. Hodge C, Marra F, Marzolini C, Boyle A, Gibbons S, Siccardi M, Burger D, Back D, Khoo S. Drug interactions: a review of the unseen danger of experimental COVID-19 therapies. J Antimicrob Chemother. 2020 12 01; 75(12):3417-3424. PMID: 32750131.
      Citations: 8     Fields:    Translation:HumansCellsPHPublic Health
    5. Marzolini C, Stader F, Leuppi-Taegtmeyer A, Stoeckle M, Battegay M, Sendi P. Sex Differences in Lopinavir Concentrations and Occurrence of Marked QTc Prolongation Episodes in Patients with COVID-19. Drug Saf. 2021 02; 44(2):255-257. PMID: 33245507.
      Citations: 1     Fields:    Translation:Humans
    6. Stader F, Khoo S, Stoeckle M, Back D, Hirsch HH, Battegay M, Marzolini C. Stopping lopinavir/ritonavir in COVID-19 patients: duration of the drug interacting effect. J Antimicrob Chemother. 2020 10 01; 75(10):3084-3086. PMID: 32556272.
      Citations: 3     Fields:    Translation:HumansCellsPHPublic Health
    7. Marzolini C, Stader F, Stoeckle M, Franzeck F, Egli A, Bassetti S, Hollinger A, Osthoff M, Weisser M, Gebhard CE, Baettig V, Geenen J, Khanna N, Tschudin-Sutter S, Mueller D, Hirsch HH, Battegay M, Sendi P. Effect of Systemic Inflammatory Response to SARS-CoV-2 on Lopinavir and Hydroxychloroquine Plasma Concentrations. Antimicrob Agents Chemother. 2020 08 20; 64(9). PMID: 32641296.
      Citations: 18     Fields:    Translation:HumansCellsPHPublic Health
    8. Marzolini C, Battegay M, Sendi P, Back DJ. Prescribing in COVID-19 patients: Should we take into account inflammation? Br J Clin Pharmacol. 2021 03; 87(3):719-721. PMID: 32820554.
      Citations:    Fields:    Translation:Humans
    9. Back D, Marzolini C, Hodge C, Marra F, Boyle A, Gibbons S, Burger D, Khoo S. COVID-19 treatment in patients with comorbidities: Awareness of drug-drug interactions. Br J Clin Pharmacol. 2021 01; 87(1):212-213. PMID: 32384171.
      Citations: 12     Fields:    Translation:Humans